Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.
Breast Cancer Res
; 21(1): 71, 2019 05 29.
Article
in En
| MEDLINE
| ID: mdl-31142370
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyridines
/
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Breast Cancer Res
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article
Affiliation country:
Italy